| 1.4 |
5.7 |
GO:0032597 |
B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 0.8 |
3.9 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.6 |
1.7 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.5 |
1.6 |
GO:0060128 |
corticotropin hormone secreting cell differentiation(GO:0060128) |
| 0.5 |
3.1 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.5 |
1.5 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.5 |
2.5 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.5 |
10.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.4 |
1.3 |
GO:2000309 |
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.4 |
1.7 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.4 |
1.3 |
GO:0036304 |
umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 0.4 |
3.5 |
GO:2000620 |
innate vocalization behavior(GO:0098582) positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.4 |
1.9 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.4 |
1.5 |
GO:1903860 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.4 |
2.1 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 0.3 |
1.3 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 |
1.0 |
GO:1904897 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.3 |
1.9 |
GO:0089712 |
L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.3 |
0.9 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
0.9 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 |
0.9 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.3 |
0.9 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.3 |
0.6 |
GO:0003358 |
noradrenergic neuron development(GO:0003358) |
| 0.3 |
1.7 |
GO:0002225 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.3 |
0.8 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.3 |
1.1 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.3 |
1.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.3 |
1.4 |
GO:0009137 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 |
1.1 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 |
1.8 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.3 |
0.8 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 |
1.0 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.2 |
0.7 |
GO:0051596 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
0.2 |
GO:1900019 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.2 |
1.2 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.2 |
2.4 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.2 |
0.7 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.2 |
0.7 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 |
2.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
3.0 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.2 |
0.7 |
GO:0048560 |
establishment of anatomical structure orientation(GO:0048560) |
| 0.2 |
2.0 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 |
0.7 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.2 |
2.7 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.2 |
2.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
3.6 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
0.9 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 |
0.9 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.2 |
0.7 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.2 |
0.7 |
GO:1905064 |
negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.2 |
1.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
1.3 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 |
0.6 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.2 |
0.6 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 |
2.7 |
GO:0038129 |
ERBB3 signaling pathway(GO:0038129) |
| 0.2 |
0.6 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
0.6 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.2 |
0.6 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.2 |
0.2 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.2 |
0.8 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
0.6 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 |
0.6 |
GO:0048867 |
stem cell fate determination(GO:0048867) |
| 0.2 |
0.6 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.2 |
1.1 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.2 |
0.4 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.2 |
0.7 |
GO:0070982 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.2 |
0.7 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 |
1.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 |
0.9 |
GO:1901091 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.2 |
0.5 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.2 |
1.6 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.2 |
0.5 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.2 |
0.7 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.2 |
0.9 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 0.2 |
0.5 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.2 |
0.5 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.2 |
0.5 |
GO:0043396 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.2 |
2.1 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.2 |
0.7 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.2 |
0.7 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
0.8 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.2 |
0.5 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 |
0.6 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.2 |
0.2 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 |
1.1 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.2 |
1.0 |
GO:2000468 |
negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.2 |
0.5 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 |
0.8 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
1.5 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 |
0.5 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
0.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
0.5 |
GO:0001796 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.2 |
0.6 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.1 |
0.6 |
GO:0060197 |
cloacal septation(GO:0060197) |
| 0.1 |
1.3 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.1 |
0.6 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
3.3 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
1.4 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
3.4 |
GO:0060211 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.6 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.1 |
1.1 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.1 |
0.1 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.1 |
0.4 |
GO:0051463 |
negative regulation of cortisol secretion(GO:0051463) |
| 0.1 |
0.3 |
GO:1903973 |
negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 0.1 |
0.3 |
GO:0071812 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.1 |
0.1 |
GO:0070256 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.1 |
0.5 |
GO:0015766 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
1.8 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 |
0.9 |
GO:0030421 |
defecation(GO:0030421) |
| 0.1 |
0.3 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.1 |
0.9 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
1.6 |
GO:0021853 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 |
0.5 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
2.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.8 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.1 |
0.3 |
GO:1903937 |
response to acrylamide(GO:1903937) |
| 0.1 |
0.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.9 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 |
0.5 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 |
0.4 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 |
0.4 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.1 |
4.8 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.4 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.1 |
1.4 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
0.2 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.1 |
0.4 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.1 |
1.1 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 |
0.6 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
1.3 |
GO:0034625 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.7 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.1 |
0.2 |
GO:0060751 |
branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.1 |
1.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.4 |
GO:0061573 |
endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.1 |
0.6 |
GO:0007571 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.2 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.8 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
0.5 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.1 |
0.2 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.1 |
0.6 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.1 |
1.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.2 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.1 |
0.5 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 |
0.4 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.3 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.1 |
0.5 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
0.4 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
0.1 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.1 |
0.9 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.1 |
1.2 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
1.4 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.8 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.4 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.1 |
0.2 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.1 |
0.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.5 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.4 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 |
0.3 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.1 |
0.4 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 |
0.3 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.1 |
0.3 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.1 |
0.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
2.3 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.3 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.1 |
0.7 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.1 |
0.4 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.7 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.1 |
0.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
2.2 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.1 |
0.6 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
1.7 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) |
| 0.1 |
0.1 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.1 |
0.1 |
GO:1903243 |
negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.1 |
2.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.9 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 |
1.2 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.5 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
1.2 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.3 |
GO:0061536 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.3 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.1 |
0.3 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.6 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.6 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.1 |
0.1 |
GO:0060723 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 |
0.3 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.4 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.1 |
0.4 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.1 |
0.5 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.7 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.4 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
0.8 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.4 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.7 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
1.8 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.7 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.1 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.1 |
0.7 |
GO:0061709 |
reticulophagy(GO:0061709) |
| 0.1 |
0.2 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.1 |
0.3 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 |
0.6 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.2 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
0.3 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 |
0.5 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.1 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.1 |
0.4 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
1.2 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
0.4 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.2 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.3 |
GO:0008615 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.1 |
0.3 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.1 |
0.4 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.1 |
0.2 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
0.7 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.1 |
0.6 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
1.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.1 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.1 |
0.2 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.1 |
0.4 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
0.5 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
0.2 |
GO:2000078 |
positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.1 |
0.3 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.2 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.1 |
0.6 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
0.2 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
0.3 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.3 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 |
0.2 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.2 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.1 |
0.5 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.2 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.2 |
GO:1903576 |
response to L-arginine(GO:1903576) |
| 0.1 |
0.2 |
GO:2001287 |
regulation of caveolin-mediated endocytosis(GO:2001286) negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.1 |
1.0 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.7 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
0.2 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.1 |
0.2 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.1 |
0.2 |
GO:0061182 |
negative regulation of chondrocyte development(GO:0061182) |
| 0.1 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.1 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
0.4 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.1 |
0.4 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
1.8 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
0.7 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.1 |
0.4 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.6 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.8 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
0.1 |
GO:0060458 |
right lung development(GO:0060458) |
| 0.1 |
1.2 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
1.3 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.2 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.1 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
0.7 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.1 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.2 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.1 |
0.2 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.4 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.4 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.1 |
0.5 |
GO:1901315 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.1 |
GO:0035992 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 |
0.3 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.1 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 |
0.6 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 |
0.1 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.2 |
GO:0018963 |
phthalate metabolic process(GO:0018963) |
| 0.1 |
0.3 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.3 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
0.2 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.2 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 |
0.2 |
GO:0071962 |
mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.1 |
1.0 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.1 |
0.2 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 |
0.6 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.1 |
GO:1903798 |
regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
| 0.1 |
0.5 |
GO:2000586 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 0.1 |
0.1 |
GO:0003140 |
determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
| 0.1 |
0.3 |
GO:0097646 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 |
0.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 |
0.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.1 |
0.7 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.1 |
0.1 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 |
0.2 |
GO:0097535 |
lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.1 |
0.2 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.3 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 |
0.1 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.1 |
0.5 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.2 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.1 |
0.6 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
0.2 |
GO:0060058 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.1 |
0.1 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.1 |
0.3 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 |
0.2 |
GO:0030920 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.2 |
GO:0061699 |
protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.1 |
0.1 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 |
0.3 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.2 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.4 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.1 |
0.2 |
GO:0000967 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
0.3 |
GO:2000984 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.3 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.1 |
0.6 |
GO:0010909 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
0.3 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
0.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 |
0.4 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.2 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.8 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
0.3 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.7 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
0.1 |
GO:1902823 |
neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) negative regulation of late endosome to lysosome transport(GO:1902823) |
| 0.1 |
0.2 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 0.1 |
0.4 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 |
0.2 |
GO:1904692 |
positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 0.1 |
0.3 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.1 |
0.2 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.1 |
0.2 |
GO:2000797 |
amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.1 |
0.2 |
GO:0009224 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 |
0.2 |
GO:0098957 |
anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 |
0.5 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.1 |
0.2 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.1 |
0.2 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.1 |
0.1 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.1 |
0.2 |
GO:0051714 |
positive regulation of cytolysis in other organism(GO:0051714) |
| 0.1 |
0.2 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.1 |
0.7 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.2 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
0.4 |
GO:0014859 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 |
0.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.1 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.1 |
1.5 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.2 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.1 |
0.2 |
GO:0035513 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
1.1 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.1 |
0.2 |
GO:0030472 |
mitotic spindle organization in nucleus(GO:0030472) |
| 0.1 |
0.2 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.1 |
0.2 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 |
0.1 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.1 |
0.2 |
GO:1904732 |
regulation of electron carrier activity(GO:1904732) |
| 0.1 |
0.3 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 0.1 |
0.7 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.5 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.1 |
0.1 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.2 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
0.3 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
1.0 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.1 |
0.3 |
GO:1904406 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
0.3 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 |
0.2 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.2 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 |
0.2 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
0.8 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.1 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
1.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
1.7 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
0.1 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.1 |
0.5 |
GO:0009415 |
response to water(GO:0009415) |
| 0.1 |
1.8 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 |
2.2 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
0.8 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
0.2 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
0.3 |
GO:1900151 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
2.2 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.1 |
0.2 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.9 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.1 |
0.6 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.3 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 |
0.2 |
GO:1901656 |
glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
| 0.1 |
0.2 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.0 |
0.5 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.5 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.0 |
1.0 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
1.3 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.1 |
GO:0034148 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
| 0.0 |
0.0 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.0 |
0.7 |
GO:0042355 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.3 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.0 |
0.1 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.0 |
0.3 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.0 |
0.1 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.0 |
1.0 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
0.1 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 |
0.1 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.0 |
0.6 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.1 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
| 0.0 |
0.7 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.5 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.7 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.3 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.3 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.0 |
0.0 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.0 |
0.9 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
0.4 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 |
0.2 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.0 |
0.1 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.0 |
0.2 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.0 |
0.5 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.0 |
0.0 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.0 |
0.5 |
GO:1901538 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.2 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.0 |
0.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.0 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.0 |
0.1 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.0 |
0.7 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 |
0.6 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.4 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 |
0.2 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 |
0.4 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.0 |
0.1 |
GO:0042040 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.0 |
4.9 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.7 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.1 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.0 |
1.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.3 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.0 |
0.3 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.3 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
0.1 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.0 |
0.2 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.0 |
0.2 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.0 |
0.7 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.2 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.0 |
0.2 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.2 |
GO:0052510 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.0 |
0.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.0 |
0.0 |
GO:0021855 |
hypothalamus cell migration(GO:0021855) |
| 0.0 |
0.3 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.0 |
0.3 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.0 |
0.9 |
GO:1904776 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.3 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 |
0.0 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.0 |
0.1 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.0 |
0.2 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.0 |
0.1 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 |
0.3 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.3 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.1 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.0 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.2 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
0.1 |
GO:0010266 |
response to vitamin B1(GO:0010266) |
| 0.0 |
0.5 |
GO:1902101 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.0 |
0.0 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.0 |
0.1 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.1 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.0 |
1.7 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.9 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.1 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.0 |
0.0 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.0 |
0.1 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.0 |
0.1 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.0 |
0.3 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.1 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.0 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.0 |
0.1 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 |
0.0 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.0 |
0.7 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.0 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.0 |
0.1 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.0 |
0.6 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.0 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.0 |
0.2 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.0 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.3 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.1 |
GO:0000494 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.0 |
0.6 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.4 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.0 |
0.8 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.2 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.1 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.0 |
0.1 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 0.0 |
0.0 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.0 |
2.6 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.0 |
0.4 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.5 |
GO:0003373 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.0 |
0.4 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.0 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.0 |
0.3 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.0 |
0.1 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.0 |
0.2 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.0 |
GO:0016488 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.0 |
0.3 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.2 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.0 |
0.6 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.0 |
0.6 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 |
0.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
1.0 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.0 |
0.1 |
GO:1903464 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.0 |
0.2 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.5 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.0 |
0.2 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.0 |
0.0 |
GO:0002545 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.0 |
0.1 |
GO:0072205 |
collecting duct development(GO:0072044) metanephric collecting duct development(GO:0072205) |
| 0.0 |
0.0 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.0 |
0.1 |
GO:0035419 |
activation of MAPK activity involved in innate immune response(GO:0035419) |
| 0.0 |
0.3 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.0 |
0.4 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.3 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 |
0.1 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.0 |
0.3 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 |
0.1 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.0 |
0.0 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.2 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.1 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.0 |
0.1 |
GO:0045643 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.0 |
0.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.2 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.4 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.0 |
0.3 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.4 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.0 |
0.1 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 |
0.0 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.0 |
0.2 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
0.2 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.1 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.0 |
0.1 |
GO:0071110 |
protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.0 |
0.7 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 |
0.1 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.0 |
0.4 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.0 |
0.1 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.0 |
0.6 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.0 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.0 |
0.1 |
GO:0042418 |
epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.0 |
0.2 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.2 |
GO:0002870 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.2 |
GO:0009635 |
response to herbicide(GO:0009635) |
| 0.0 |
0.2 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.2 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 |
0.1 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.0 |
0.1 |
GO:1902004 |
positive regulation of beta-amyloid formation(GO:1902004) |
| 0.0 |
0.1 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.0 |
0.3 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.1 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.2 |
GO:1903301 |
positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.2 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.0 |
0.2 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.0 |
0.2 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.1 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.0 |
0.1 |
GO:0071315 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.0 |
0.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.0 |
1.5 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.0 |
0.3 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.0 |
0.2 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.0 |
0.1 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.0 |
0.3 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.0 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.0 |
0.1 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.0 |
0.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.0 |
0.8 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 |
1.0 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
1.0 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 |
0.2 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.0 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.0 |
0.1 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.0 |
0.1 |
GO:0046080 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.0 |
0.6 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.0 |
GO:0010875 |
positive regulation of cholesterol efflux(GO:0010875) |
| 0.0 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.2 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.0 |
0.2 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 |
0.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.1 |
GO:1903750 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.0 |
0.2 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.7 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.2 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 |
0.1 |
GO:2000366 |
cardiac muscle tissue regeneration(GO:0061026) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.0 |
0.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.5 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 |
0.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.0 |
0.1 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.0 |
0.3 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) |
| 0.0 |
1.7 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
0.5 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.1 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 |
0.1 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.0 |
0.0 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.0 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.4 |
GO:1903441 |
protein localization to ciliary membrane(GO:1903441) |
| 0.0 |
0.7 |
GO:0032094 |
response to food(GO:0032094) |
| 0.0 |
0.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.1 |
GO:0019230 |
proprioception(GO:0019230) |
| 0.0 |
0.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.2 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 |
0.1 |
GO:2000755 |
regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 0.0 |
0.1 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.0 |
0.2 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.0 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 |
0.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.3 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.0 |
0.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.4 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.1 |
GO:0018012 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 |
1.2 |
GO:0045815 |
positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.0 |
0.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.1 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.0 |
0.1 |
GO:1900106 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.0 |
0.1 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.1 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.0 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.0 |
0.1 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.1 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.0 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.0 |
0.1 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 |
0.1 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 |
0.1 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.0 |
0.1 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.0 |
0.1 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.2 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.1 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.0 |
0.2 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.0 |
0.1 |
GO:0014813 |
skeletal muscle satellite cell commitment(GO:0014813) |
| 0.0 |
0.0 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.0 |
0.3 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.0 |
0.0 |
GO:0060463 |
lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.0 |
0.1 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.0 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.0 |
0.6 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.5 |
GO:0002385 |
mucosal immune response(GO:0002385) |
| 0.0 |
0.0 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.0 |
0.1 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.0 |
0.1 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.0 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.0 |
0.3 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.2 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.2 |
GO:0090650 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.0 |
0.3 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.0 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.0 |
0.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.0 |
0.9 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.1 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.1 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.0 |
0.1 |
GO:0060459 |
left lung development(GO:0060459) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.2 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.0 |
0.0 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.0 |
0.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.0 |
0.0 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.2 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.0 |
0.0 |
GO:0098877 |
neurotransmitter receptor transport to plasma membrane(GO:0098877) |
| 0.0 |
0.2 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.1 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.0 |
0.1 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 |
0.3 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.0 |
1.0 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.2 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.3 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.0 |
0.1 |
GO:0035712 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.0 |
0.8 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.3 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.0 |
0.2 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.0 |
0.0 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.0 |
0.5 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.0 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.0 |
0.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
0.1 |
GO:0035697 |
CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.0 |
0.2 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.0 |
GO:0070054 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.0 |
0.1 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.0 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 |
0.1 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.0 |
0.1 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 |
0.1 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.0 |
0.1 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.1 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.0 |
0.0 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.4 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 |
0.5 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.1 |
GO:1903259 |
exon-exon junction complex disassembly(GO:1903259) |
| 0.0 |
0.0 |
GO:1903233 |
regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.0 |
0.0 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) |
| 0.0 |
0.5 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.1 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.0 |
GO:2000439 |
positive regulation of monocyte extravasation(GO:2000439) |
| 0.0 |
0.3 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.5 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.3 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.1 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.0 |
0.0 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.0 |
0.5 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.1 |
GO:1902221 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 |
0.1 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.0 |
0.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.1 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.0 |
2.4 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.0 |
0.1 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.1 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.0 |
1.2 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.0 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.0 |
0.3 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.2 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.0 |
0.2 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.0 |
0.1 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.0 |
0.1 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
0.7 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
0.3 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.2 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.5 |
GO:0048490 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.1 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.4 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.0 |
0.1 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 |
0.0 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.0 |
0.1 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.0 |
0.2 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.0 |
GO:0045357 |
interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.0 |
0.5 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.1 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.0 |
0.0 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.0 |
0.1 |
GO:0099540 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.0 |
0.1 |
GO:0030581 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.0 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.0 |
0.1 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) |
| 0.0 |
0.1 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) |
| 0.0 |
0.1 |
GO:0051797 |
regulation of hair follicle development(GO:0051797) |
| 0.0 |
0.1 |
GO:1902905 |
positive regulation of fibril organization(GO:1902905) |
| 0.0 |
0.1 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.0 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.2 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.0 |
0.0 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.0 |
0.1 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.0 |
0.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 |
0.1 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
0.1 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.2 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.0 |
0.3 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
0.1 |
GO:0072050 |
S-shaped body morphogenesis(GO:0072050) metanephric S-shaped body morphogenesis(GO:0072284) |
| 0.0 |
1.4 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.3 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.0 |
0.0 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.0 |
0.0 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.0 |
0.2 |
GO:0033015 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 |
0.1 |
GO:0019720 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 |
0.1 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 |
0.2 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.1 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
0.3 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.0 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.0 |
0.0 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.0 |
0.0 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.2 |
GO:0043217 |
myelin maintenance(GO:0043217) |
| 0.0 |
0.4 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.3 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.0 |
0.4 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.3 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.2 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.0 |
0.2 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.1 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.0 |
0.2 |
GO:0032753 |
positive regulation of interleukin-4 production(GO:0032753) |
| 0.0 |
0.1 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.3 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.3 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.0 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.1 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.0 |
0.1 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.0 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.0 |
0.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
2.6 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.0 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.0 |
0.1 |
GO:0038155 |
interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 |
0.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.0 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.0 |
0.0 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.0 |
0.3 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.0 |
GO:1990654 |
regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
| 0.0 |
0.0 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.0 |
0.1 |
GO:0093001 |
glycolytic process through glucose-1-phosphate(GO:0061622) glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.0 |
0.0 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.7 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.0 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 |
0.1 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 |
0.2 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.0 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.0 |
0.0 |
GO:1904628 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.0 |
0.6 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.1 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.2 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 |
0.0 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 |
0.1 |
GO:0060482 |
lobar bronchus development(GO:0060482) |
| 0.0 |
0.2 |
GO:0043574 |
peroxisomal transport(GO:0043574) |
| 0.0 |
0.1 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 |
0.1 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.0 |
0.0 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
| 0.0 |
0.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.0 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.0 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.0 |
0.0 |
GO:0070920 |
regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
| 0.0 |
0.1 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.0 |
0.2 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 |
0.4 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.3 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.0 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.0 |
0.0 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.0 |
0.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.0 |
0.0 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.4 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.1 |
GO:1901838 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 |
0.1 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.0 |
0.2 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.1 |
GO:0071051 |
snoRNA 3'-end processing(GO:0031126) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.0 |
0.1 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 |
0.5 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.1 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 |
0.0 |
GO:0036476 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.0 |
0.1 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.2 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.0 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.6 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.1 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 |
0.3 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.0 |
GO:1904751 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.0 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.0 |
0.1 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 |
0.0 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.0 |
0.1 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 |
1.0 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.2 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.0 |
0.0 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.0 |
0.0 |
GO:0035739 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.0 |
0.1 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.0 |
GO:0003352 |
regulation of cilium movement(GO:0003352) |
| 0.0 |
0.1 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.0 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 |
0.2 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.0 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.0 |
0.1 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.0 |
0.1 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.0 |
0.1 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
0.1 |
GO:0048007 |
antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.0 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.0 |
0.0 |
GO:0071878 |
negative regulation of adrenergic receptor signaling pathway(GO:0071878) retrograde trans-synaptic signaling(GO:0098917) |
| 0.0 |
0.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.1 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.0 |
0.6 |
GO:1901016 |
regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.0 |
0.2 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 |
0.0 |
GO:1904528 |
positive regulation of microtubule binding(GO:1904528) |
| 0.0 |
0.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.4 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.1 |
GO:0016553 |
base conversion or substitution editing(GO:0016553) |
| 0.0 |
0.2 |
GO:1902253 |
regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
| 0.0 |
0.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.0 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.0 |
0.2 |
GO:1900015 |
regulation of cytokine production involved in inflammatory response(GO:1900015) |
| 0.0 |
0.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.0 |
GO:0002774 |
Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.0 |
0.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.2 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 |
0.1 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 |
0.0 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 |
0.1 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.0 |
0.1 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.0 |
0.1 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |